Full-Time

Quality Assurance Specialist 2-3

Deadline 11/16/26
Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Springfield, MO, USA

In Person

Night shift required.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
GMP
Quality Assurance (QA)

Get referred to Curia

See people who can refer or advise you

Requirements
  • A bachelor's degree in Life Sciences or a related field; alternate fields of study may be considered in combination with significant industry experience.
  • A minimum of 6–8 years of quality assurance experience in pharmaceutical, biotechnology, medical device, or a current Good Manufacturing Practice Food and Drug Administration-regulated industry.
  • Strong familiarity with regulatory requirements including ICH Q7, Q9, Q10, and/or 21 CFR 210 and 211.
  • Excellent written and verbal communication skills, including the ability to present information clearly to management and peers.
  • Strong problem-solving and conflict resolution skills.
  • Ability to work independently and proactively while collaborating effectively across departments.
  • Ability to manage multiple priorities simultaneously with attention to detail and self-direction.
  • Working knowledge of Microsoft Office or other relevant software.
  • Must pass a background check.
  • Must pass a drug screen.
Responsibilities
  • Provide on-the-floor quality assurance oversight to manufacturing operations, proactively identifying compliance risks and coordinating day-to-day quality activities as needed.
  • Represent Quality Assurance when issues require immediate corrective action, ensuring actions are appropriate and correctly documented to support traceability and investigation substantiation.
  • Assist in or lead deviation and investigation processes, including initiation, immediate corrective action, and resolution.
  • Track and follow up on Deviations, Change Controls, Investigations, and CAPAs to ensure timely closure.
  • Participate in quality improvement initiatives, including their development and implementation.
  • Author, revise, review, and approve Quality Management System documents, including SOPs, CAPAs, Deviations, Change Controls, test methods, protocols, validation documentation, certificates of analysis, and equipment qualification documentation.
  • Support the compilation and maintenance of quality documentation and systems to ensure inspection readiness for domestic and international regulatory bodies, including ISO, FDA, QP, and EMEA.
  • Develop, support, and maintain Quality System metrics for management review.
  • Assist in training personnel in current Good Manufacturing Practices and the company quality system to ensure real-time compliance.
  • Participate in and support internal and external audit programs, including planning, conducting audits, weekly walkthroughs, and preparing audit reports.
  • Participate in regulatory, client, and external supplier qualification audits.
  • With appropriate supervision, respond to or manage client communications regarding manufacturing, testing, and documentation issues.
  • Support Quality Assurance team members and internal project teams to keep client timelines on schedule, communicating proactively with customer contacts as needed.
  • Perform documentation in compliance with ALCOA++ principles and site standard operating procedures.
  • Adhere to applicable current Good Manufacturing Practice documents, including standard operating procedures, batch records, protocols, change controls, and controlled forms.
  • Keep required current Good Manufacturing Practice training current and escalate quality concerns with proposed solutions to the Quality department.
Desired Qualifications
  • Experience working with third-party contract manufacturing in the pharmaceutical industry.
  • May be required to pass Occupational Health Screening.
  • May be required to obtain and maintain gowning certification.
  • May be required to obtain and maintain media qualification.

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.